```html

Molluscum Dermatitis

Overview

Molluscum dermatitis is an inflammatory skin reaction that develops around the characteristic lesions of molluscum contagiosum. While the virus itself (a poxvirus) causes small, umbilicated papules, the surrounding skin can become red, itchy, and inflamed—this secondary inflammation is called molluscum dermatitis.

• Who it affects: Most common in children 1–12 years old, but also seen in adolescents and adults, especially those with compromised immunity (e.g., HIV infection).
• Prevalence: Molluscum contagiosum affects up to 2–5 % of children worldwide. Dermatitis develops in an estimated 10–30 % of those lesions, especially when lesions are scratched or become infected.
• Transmission: Direct skin‑to‑skin contact, sexual contact (in adults), or fomites such as towels and clothing.

Symptoms

The clinical picture includes the classic molluscum lesions plus inflammatory changes. The following list covers all reported symptoms.

Core Molluscum Lesions

• Small (< 2–5 mm) dome‑shaped papules.
• Central indentation or “umbilication”.
• Skin‑colored, pink, or pearly white appearance.
• Usually painless but can become tender if inflamed.

Dermatitis Features

• Redness (erythema) surrounding one or more lesions.
• Intense itching (pruritus) that may lead to scratching.
• Swelling (edema) and warmth in the affected area.
• Flaking or scaling skin.
• Secondary crusting or oozing if the skin becomes excoriated.
• In rare cases, a diffuse eczematous rash extending beyond the immediate lesion.

Systemic Symptoms (Uncommon)

• Low‑grade fever if a bacterial super‑infection occurs.
• Generalized malaise or lymphadenopathy in immunocompromised patients.

Causes and Risk Factors

Primary Cause – Molluscum Contagiosum Virus (MCV)

The disease is caused by the Molluscum contagiosum virus, a member of the Poxviridae family. The virus infects epidermal keratinocytes, leading to the formation of the characteristic papules.

Why Dermatitis Develops

• Mechanical irritation: Scratching or rubbing disrupts the skin barrier.
• Secondary bacterial infection: Staphylococcus aureus or Streptococcus pyogenes can colonize compromised skin, triggering inflammation.
• Immune response: In some individuals the immune system reacts vigorously to viral antigens, producing an eczematous reaction.

Risk Factors

• Age 1–12 years (most common).
• Close skin‑to‑skin contact (daycare, sports).
• Sexual activity (adults).
• Immunosuppression – HIV, organ transplantation, chemotherapy.
• Atopic dermatitis or other pre‑existing skin conditions.
• Use of humid environments (swimming pools, hot tubs).

Diagnosis

Clinical Evaluation

Diagnosis is primarily clinical. A dermatologist or primary‑care provider will examine the lesions and look for the classic central umbilication.

Diagnostic Tools

• Dermatoscopy: Shows a central plug with surrounding vascular pattern.
• Skin scraping & microscopy: Reveals large, eosinophilic cytoplasmic inclusion bodies (“Molluscum bodies”).
• PCR testing: Rarely needed but can confirm MCV DNA in atypical cases.
• Bacterial culture: If secondary infection is suspected (purulent discharge, increased pain).

Differential Diagnosis

Conditions that can mimic molluscum dermatitis include:

• Common warts (HPV).
• Basal cell carcinoma (rare in children).
• Folliculitis or impetigo.
• Atopic eczema with secondary infection.

Treatment Options

When to Treat?

Most molluscum lesions resolve spontaneously within 6–18 months. Treatment is generally recommended when:

• Lesions are numerous or widespread.
• Dermatitis causes severe itching or secondary infection.
• Cosmetic concerns are significant (face, hands).
• Patient is immunocompromised.

Topical Therapies

• Imiquimod 5% cream: Immune response modifier; applied 3×/week for up to 16 weeks. Evidence shows modest clearance rates (≈30‑40 %) and can reduce dermatitis.<sup>1</sup>
• Podophyllotoxin 0.5% solution: Applied twice daily for 3 days, repeated after 1 week.
• Cryotherapy (liquid nitrogen): Freezes lesions; can provoke dermatitis initially but often leads to rapid resolution.
• Topical corticosteroids: Low‑ to mid‑strength (e.g., hydrocortisone 1% or triamcinolone 0.1%) to control the eczematous component. Use short courses (5‑7 days) to avoid skin atrophy.
• Antibiotic ointments: Mupirocin or fusidic acid for secondary bacterial infection.

Procedural Options

• Curettage: Physical removal with a small curette; high cure rate (>90 %) but may cause scarring if not performed skillfully.
• Laser therapy: CO₂ or pulsed dye lasers—effective for resistant lesions, especially on the face.
• Electrodesiccation: Uses electric current to destroy lesions.

Systemic Options (Rare)

In severe or refractory cases, especially in immunocompromised hosts, oral antivirals (e.g., cidofovir) have been used under specialist supervision.

Adjunctive Measures

• Antihistamines (e.g., cetirizine) for itching.
• Emollients and barrier creams to protect scratched skin.
• Warm compresses to reduce inflammation.

Living with Molluscum Dermatitis

Daily Skin Care

• Wash affected areas twice daily with a mild, fragrance‑free cleanser.
• Pat skin dry; avoid vigorous rubbing.
• Apply a thin layer of a hypoallergenic moisturizer after washing.
• Use over‑the‑counter 1 % hydrocortisone cream for flare‑ups, no longer than 7 days without a doctor’s review.

Itch Management

• Keep nails trimmed short to minimize damage from scratching.
• Cold compresses (10‑15 min) can provide quick relief.
• Consider oral antihistamines at night if itching disrupts sleep.

Clothing & Lifestyle

• Wear loose, breathable clothing (cotton) to reduce friction.
• Change socks, underwear, and towels daily; avoid sharing personal items.
• For athletes, shower immediately after practice and use disinfected equipment.

Psychosocial Tips

• Explain to children that the condition is not contagious through casual contact (only via direct skin contact).
• Provide reassurance—most lesions disappear without scarring.
• Seek counseling if lesions cause significant embarrassment or anxiety.

Prevention

• Hand hygiene: Wash hands after touching lesions or any potentially contaminated surface.
• Avoid sharing personal items: Towels, razors, clothing.
• Protect skin during sports: Use barrier creams or protective clothing.
• Safe sexual practices: Use condoms; discuss with partners.
• Maintain immune health: Balanced diet, adequate sleep, and prompt management of any underlying immunosuppressive condition.
• Early treatment: Prompt removal of lesions reduces the risk of dermatitis and spread.

Complications

• Secondary bacterial infection: May lead to impetigo, cellulitis, or abscess formation.
• Scarring: Aggressive scratching or improper curettage can cause permanent scars.
• Extended disease course: In immunocompromised patients lesions may persist for years.
• Psychological impact: Visible lesions, especially on the face, can affect self‑esteem.

When to Seek Emergency Care

References

1. Glasziou, P., et al. "Imiquimod for molluscum contagiosum." Cochrane Database of Systematic Reviews, 2020.
2. Mayo Clinic. "Molluscum contagiosum." https://www.mayoclinic.org/diseases-conditions/molluscum-contagiosum/symptoms-causes/syc-20375212 (accessed May 2026).
3. CDC. "Molluscum contagiosum – Epidemiology and Prevention." https://www.cdc.gov/mmwr/volumes/71/wr/pdfs/mm7112e5-H.pdf (accessed May 2026).
4. World Health Organization. "Skin infections and viral skin diseases." WHO Fact Sheets, 2022.
5. Cleveland Clinic. "Molluscum Contagiosum (Dermatitis)." https://my.clevelandclinic.org/health/diseases/16483-molluscum-contagiosum (accessed May 2026).

```